18 related articles for article (PubMed ID: 7653997)
1. Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present.
Huff SE; Winter JM; Dealwis CG
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740940
[TBL] [Abstract][Full Text] [Related]
2. Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs.
Shelton J; Lu X; Hollenbaugh JA; Cho JH; Amblard F; Schinazi RF
Chem Rev; 2016 Dec; 116(23):14379-14455. PubMed ID: 27960273
[TBL] [Abstract][Full Text] [Related]
3. A docking model of human ribonucleotide reductase with flavin and phenosafranine.
Priya PL; Shanmughavel P
Bioinformation; 2009 Sep; 4(3):123-6. PubMed ID: 20198185
[TBL] [Abstract][Full Text] [Related]
4. Phase I and pharmacologic study of oral (E)-2'-deoxy-2'-(fluoromethylene) cytidine: on a daily x 5-day schedule.
Masuda N; Negoro S; Takeda K; Takifuji N; Hirashima T; Yana T; Kurata N; Kuwabara T; Kobayashi S; Kudoh S; Matsui K; Takada M; Fukuoka M
Invest New Drugs; 1998-1999; 16(3):245-54. PubMed ID: 10360604
[TBL] [Abstract][Full Text] [Related]
5. Antitumor and radiosensitizing effects of (E)-2'-deoxy-2'-(fluoromethylene) cytidine, a novel inhibitor of ribonucleoside diphosphate reductase, on human colon carcinoma xenografts in nude mice.
Sun LQ; Li YX; Guillou L; Mirimanoff RO; Coucke PA
Cancer Res; 1997 Sep; 57(18):4023-8. PubMed ID: 9307288
[TBL] [Abstract][Full Text] [Related]
6. Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase.
Bitonti AJ; Dumont JA; Bush TL; Cashman EA; Cross-Doersen DE; Wright PS; Matthews DP; McCarthy JR; Kaplan DA
Cancer Res; 1994 Mar; 54(6):1485-90. PubMed ID: 8137252
[TBL] [Abstract][Full Text] [Related]
7. A ribonucleotide reductase inhibitor, MDL 101,731, induces apoptosis and elevates TRPM-2 mRNA levels in human prostate tumor xenografts.
Wright PS; Cross-Doersen D; Th'ng JP; Guo XW; Crissman HA; Bradbury EM; Montgomery LR; Thompson FY; Loudy DE; Johnston JO; Bitonti AJ
Exp Cell Res; 1996 Jan; 222(1):54-60. PubMed ID: 8549673
[TBL] [Abstract][Full Text] [Related]
8. Decreased vascular endothelial growth factor expression associated with tumor regression induced by (E)-2'-deoxy-2'-(fluoromethylene)cytidine (MDL 101,731).
Woessner RD; Loudy DE; Wallace CD; Montgomery LR; Cross-Doersen DE; Bush TL; Lewis MT; Prakash N; Bitonti AJ; Wright PS
Oncol Res; 1997; 9(10):543-52. PubMed ID: 9507532
[TBL] [Abstract][Full Text] [Related]
9. (E)-2'-deoxy-2'-(fluoromethylene) cytidine potentiates radioresponse of two human solid tumor xenografts.
Sun LQ; Li YX; Guillou L; Coucke PA
Cancer Res; 1998 Dec; 58(23):5411-7. PubMed ID: 9850073
[TBL] [Abstract][Full Text] [Related]
10. Response of human colon and prostate tumor xenografts to (E)-2'-deoxy-2'-(fluoromethylene) cytidine, an inhibitor of ribonucleotide reductase.
Bitonti AJ; Bush TL; Lewis MT; Sunkara PS
Anticancer Res; 1995; 15(4):1179-82. PubMed ID: 7653997
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
